Dose evaluation method, irradiation condition selection method and treatment plan generation apparatus

By acquiring tissue material information and assessing radiation absorbed dose using conjugate flux, the problem of time-consuming dose distribution calculations in radiotherapy has been solved, enabling rapid selection of appropriate irradiation conditions and shortening treatment planning time.

WO2024245085A1PCT designated stage expired Publication Date: 2024-12-05NEUBORON THERAPY SYST LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/094828
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-01
Filing Date
2024-05-23
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

In current radiotherapy, dose distribution calculation is time-consuming, making it difficult to select appropriate irradiation conditions within a reasonable timeframe, thus affecting the optimization of treatment plans.

Method used

By acquiring tissue material information, determining the conjugate flux, and assessing the radiation absorbed dose in conjunction with irradiation conditions, the dose distribution under multiple irradiation conditions can be rapidly assessed using conjugate flux calculation.

Benefits of technology

Rapid assessment of absorbed radiation dose simplifies the selection of irradiation conditions and shortens the time required for treatment planning.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024094828_05122024_PF_FP_ABST
    Figure CN2024094828_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The present application relates to a dose evaluation method, an irradiation condition selection method and a treatment plan generation apparatus. The dose evaluation method comprises: acquiring tissue material information; determining a conjugate flux corresponding to a tissue material according to the tissue material information; and on the basis of an irradiation condition in combination with the conjugate flux corresponding to the tissue material, obtaining a radiation absorption dose corresponding to the tissue material under the irradiation condition. By using the method, a radiation absorption dose corresponding to a tissue material can be quickly calculated, thereby improving the efficiency of dose calculation under a plurality of irradiation conditions, and radiation absorption doses corresponding to each tissue material under different irradiation conditions can be quickly evaluated, so as to facilitate the quick selection of a suitable irradiation condition from among the plurality of irradiation conditions, thereby greatly shortening the formulation time of a treatment plan.
Need to check novelty before this filing date? Find Prior Art

Description

Dose assessment method, irradiation condition selection method and treatment plan generation device Technical Field

[0001] The present application relates to the field of radiotherapy technology, and in particular to a dose assessment method, an irradiation condition selection method, and a treatment plan generation device. Background Art

[0002] Radiotherapy is a medical method of treating cancer by using radiation to deposit energy around cancer cells to kill them. Depending on the type of radiation, radiotherapy can be divided into photon radiotherapy, electron radiotherapy, proton and heavy ion radiotherapy, and boron neutron capture therapy.

[0003] To ensure that the radiation particles kill as many cancer cells as possible while minimizing damage to normal cells, a computed tomography (CT) or positron emission tomography (PET) scan is usually performed before treating the patient. The tissue material information of the object to be irradiated is obtained based on the scan results. A computational model is then established based on this tissue material information and the radiation source to simulate the transport process of the radiation particles in the object to be irradiated. Ultimately, the dose distribution of the radiation particles in the object to be irradiated is determined, and a treatment plan with the optimal dose distribution for the patient is then selected as the treatment plan.

[0004] In the process of generating the above-mentioned treatment plan, calculating the dose distribution of the patient's irradiated area plays a decisive role in the effectiveness of radiotherapy. Dose distribution calculation is usually carried out under given irradiation conditions, and the selection of irradiation conditions is often based on the physicist's own experience, which has great uncertainty. In traditional technology, dose distribution is mainly obtained by simulating the motion process of radiation particles using the Monte Carlo method. By simulating the transport process of radiation particles in the irradiated body under different irradiation conditions, the dose distribution of patients under different irradiation conditions is obtained. For traditional radiotherapy, it is necessary to simulate the motion process of photons and electrons, while for other radiation irradiation treatments, it is necessary to simulate the motion process of neutrons and photons.

[0005] However, the simulation and calculation process of the above method is time-consuming and memory-intensive. Furthermore, there are many pre-given irradiation conditions, and simulating and calculating each of them one by one using the above method would take a long time. Therefore, it is difficult to select appropriate irradiation conditions within a reasonable calculation time, which is not conducive to the optimization calculation of the treatment plan.

[0006] Summary of the Invention

[0007] Based on this, it is necessary to provide a dose assessment method, an irradiation condition selection method and a treatment plan generation device that can quickly assess the dose and quickly select appropriate irradiation conditions to address the above technical problems.

[0008] In a first aspect, the present application provides a method for assessing radiation therapy dose, the method comprising:

[0009] Obtaining information about organizational materials;

[0010] determining a conjugate flux corresponding to the tissue material according to the tissue material information;

[0011] Based on the irradiation conditions and combined with the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to the tissue material under the irradiation conditions is obtained.

[0012] In one embodiment, determining the conjugate flux corresponding to the tissue material according to the tissue material information includes:

[0013] Determining a flux dose conversion factor corresponding to the tissue material according to the element information of the tissue material in the tissue material information;

[0014] The conjugate flux corresponding to the tissue material is determined based on the flux dose conversion factor corresponding to the tissue material.

[0015] In one embodiment, the element information includes element composition and element ratio. Determining the flux dose conversion factor corresponding to the tissue material based on the element information of the tissue material in the tissue material information includes:

[0016] Obtain the density of each nuclide in the tissue material based on the element composition and element proportion;

[0017] Obtain the flux dose conversion factor corresponding to each nuclide;

[0018] The flux dose conversion factor corresponding to each nuclide and the density of each nuclide are combined to determine the flux dose conversion factor corresponding to the tissue material.

[0019] In one embodiment, the flux dose conversion factor corresponding to each nuclide and the density of each nuclide are combined to determine the flux dose conversion factor corresponding to the tissue material using the following formula: Kerma = ∑ρ i Kerma i ;

[0020] Among them, ρ i represents the density of the i-th nuclide, Kerma i represents the flux dose conversion factor corresponding to the i-th nuclide.

[0021] In one embodiment, the conjugate flux corresponding to the tissue material is determined based on the flux dose conversion factor corresponding to the tissue material, using the following formula:

[0022] in, represents the conjugate flux, P1 and P2 represent different particle state parameters, represents the conjugate flux of particles in the P1 state, Kerma represents the flux dose conversion factor, K * represents the conjugate nucleus, K * (P2→P1) represents the probability that a particle reaches the P2 state from the P1 state through collision reaction.

[0023] In one embodiment, based on the irradiation conditions and in combination with the conjugate flux corresponding to the tissue material, obtaining the radiation absorbed dose corresponding to the tissue material under the irradiation conditions includes:

[0024] Based on the irradiation conditions, determining the source term distribution corresponding to the irradiation conditions, wherein the source term distribution is used to characterize the distribution function of the particle source under the irradiation conditions;

[0025] The radiation absorbed dose corresponding to the tissue material is obtained according to the source term distribution and the conjugate flux corresponding to the tissue material.

[0026] In a second aspect, the present application also provides a method for selecting irradiation conditions, the method comprising:

[0027] Combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to each tissue material is obtained;

[0028] At least one appropriate irradiation condition is selected according to the radiation absorption dose corresponding to each tissue material.

[0029] In one embodiment, at least one suitable irradiation condition is selected based on the radiation absorbed dose corresponding to each tissue material, including:

[0030] If the radiation absorbed dose corresponding to each tissue material meets the preset conditions, the irradiation condition is accepted.

[0031] In one embodiment, the tissue material includes at least tumor tissue material and vital organ tissue material. If the radiation absorption dose corresponding to each tissue material meets a preset condition, the irradiation condition is accepted, including:

[0032] If the radiation absorption dose corresponding to the tumor tissue material is greater than a first preset threshold, and the radiation absorption dose corresponding to the vital organ tissue material is less than a second preset threshold, the irradiation condition is accepted.

[0033] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes:

[0034] Based on at least one preset region of interest, a tissue material corresponding to the region of interest is determined.

[0035] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes:

[0036] Based on at least one preset region of interest and in combination with the concentration distribution of the targeting element in the region of interest, the tissue material corresponding to the region of interest is determined.

[0037] In one embodiment, appropriate irradiation conditions are selected based on the radiation absorbed dose corresponding to each tissue material, including:

[0038] Determine the radiation absorbed dose of the region of interest based on the radiation absorbed doses corresponding to all tissue materials in the region of interest;

[0039] Select appropriate irradiation conditions based on the radiation absorbed dose of the area of ​​interest.

[0040] In a third aspect, the present application further provides a method for generating a treatment plan, the method comprising:

[0041] Combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to each tissue material is obtained;

[0042] Selecting at least one appropriate irradiation condition according to the radiation absorbed dose corresponding to each tissue material;

[0043] Generate a treatment plan based on appropriate irradiation conditions.

[0044] In one embodiment, at least one suitable irradiation condition is selected based on the radiation absorbed dose corresponding to each tissue material, including:

[0045] If the radiation absorbed dose corresponding to each tissue material meets the preset conditions, the irradiation condition is accepted.

[0046] In one embodiment, the tissue material includes at least tumor tissue material and vital organ tissue material. If the radiation absorption dose corresponding to each tissue material meets a preset condition, the irradiation condition is accepted, including:

[0047] If the radiation absorption dose corresponding to the tumor tissue material is greater than a first preset threshold, and the radiation absorption dose corresponding to the vital organ tissue material is less than a second preset threshold, the irradiation condition is accepted.

[0048] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes:

[0049] Based on at least one preset region of interest, a tissue material corresponding to the region of interest is determined.

[0050] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes:

[0051] Based on at least one preset region of interest and in combination with the concentration distribution of the targeting element in the region of interest, the tissue material corresponding to the region of interest is determined.

[0052] In one embodiment, appropriate irradiation conditions are selected based on the radiation absorbed dose corresponding to each tissue material, including:

[0053] Determine the radiation absorbed dose of the region of interest based on the radiation absorbed doses corresponding to all tissue materials in the region of interest;

[0054] Select appropriate irradiation conditions based on the radiation absorbed dose of the area of ​​interest.

[0055] In one embodiment, generating a treatment plan based on appropriate irradiation conditions includes:

[0056] The corresponding flux is determined according to appropriate irradiation conditions, and the dose distribution is calculated based on the flux using a Monte Carlo simulation program.

[0057] In a fourth aspect, the present application further provides a treatment plan generating device, comprising:

[0058] Radiation source module, used to establish source term information according to different irradiation conditions;

[0059] Medical imaging data module, used to obtain tissue material information based on medical imaging data and establish a three-dimensional voxel tissue model;

[0060] The dose assessment module is used to determine the conjugate flux corresponding to the tissue material according to the tissue material information, and to obtain the radiation absorbed dose corresponding to each tissue material by combining the source term information and the conjugate flux corresponding to the tissue material;

[0061] An irradiation condition selection module is used to select at least one suitable irradiation condition according to the radiation absorption dose corresponding to each tissue material;

[0062] The treatment plan generation module is used to generate a treatment plan based on appropriate irradiation conditions.

[0063] In a fifth aspect, the present application further provides a radiotherapy system, the system comprising:

[0064] a beam generating device for generating a therapeutic beam;

[0065] a beam adjusting device for adjusting the therapeutic beam generated by the beam generating device;

[0066] a treatment plan generating device for establishing source term information according to different irradiation conditions, acquiring tissue material information based on medical imaging data, establishing a three-dimensional voxel tissue model, determining a conjugate flux corresponding to the tissue material according to the tissue material information, combining the source term information and the conjugate flux corresponding to the tissue material to obtain a radiation absorbed dose corresponding to each tissue material, selecting at least one appropriate irradiation condition based on the radiation absorbed dose corresponding to each tissue material, and generating a treatment plan based on the appropriate irradiation condition;

[0067] The beam control device is used to retrieve the corresponding treatment plan from the treatment plan generating device and control the beam generating device to execute the treatment plan.

[0068] In a sixth aspect, the present application further provides a radiotherapy system, the system comprising a memory and a processor;

[0069] Memory for storing computer programs;

[0070] A processor is used to implement the radiotherapy dose assessment method provided in the first aspect of the present application, the irradiation condition selection method provided in the second aspect of the present application, or the treatment plan generation method provided in the third aspect of the present application when executing the computer program.

[0071] In the seventh aspect, the present application also provides a computer-readable storage medium, which stores a computer program. When the computer program is executed by a processor, it implements the radiotherapy dose assessment method provided in the first aspect of the present application, the irradiation condition selection method provided in the second aspect of the present application, or the treatment plan generation method provided in the third aspect of the present application.

[0072] The above-mentioned radiotherapy dose assessment method obtains tissue material information, determines the conjugate flux corresponding to the tissue material based on the tissue material information, and then, based on the irradiation conditions and the conjugate flux corresponding to the tissue material, obtains the radiation absorbed dose corresponding to the tissue material under the irradiation conditions. Because the combined irradiation conditions and conjugate flux are relatively simple to assess the radiation absorbed dose, the above-mentioned method can quickly assess the radiation absorbed dose corresponding to the tissue material.

[0073] Furthermore, since the conjugate flux is independent of the source term S, the number of times it is calculated is only related to the counting target of the tissue material to be considered. Regardless of how the irradiation conditions change, the conjugate flux corresponding to the tissue material is determined, and the radiation absorption dose corresponding to the tissue material under multiple different irradiation conditions can be quickly obtained. The radiation absorption dose of each region of interest under multiple different irradiation conditions can also be quickly obtained. Therefore, in the above-mentioned irradiation condition selection method, when it is necessary to select at least one suitable irradiation condition from multiple different irradiation conditions, it is only necessary to calculate the conjugate flux several times to evaluate the radiation absorption dose of each tissue material or each region of interest under multiple different irradiation conditions. Based on the radiation absorption dose under multiple different irradiation conditions, the appropriate irradiation condition can be quickly selected.

[0074] Furthermore, in the above-mentioned treatment plan generation method, since a suitable irradiation condition can be quickly selected from a plurality of different irradiation conditions, the time for formulating the treatment plan is greatly shortened. BRIEF DESCRIPTION OF THE DRAWINGS

[0075] FIG1 is a diagram of an application environment in one embodiment;

[0076] FIG2 is a schematic flow chart of a method for evaluating radiation therapy dose according to an embodiment;

[0077] FIG3 is a schematic flow chart of a method for selecting irradiation conditions in one embodiment;

[0078] FIG4 is a schematic flow chart of a method for generating a treatment plan in one embodiment;

[0079] FIG5 is a structural block diagram of a treatment plan generating device according to an embodiment;

[0080] FIG6 is a block diagram of a radiotherapy system according to an embodiment;

[0081] FIG. 7 is a structural block diagram of a radiotherapy system according to another embodiment. DETAILED DESCRIPTION

[0082] In order to make the purpose, technical solutions and advantages of this application more clear, the following further describes this application in detail with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain this application and are not intended to limit this application.

[0083] The radiotherapy dose assessment method, irradiation condition selection method, and treatment plan generation method provided in the embodiments of the present application can be applied in the application environment shown in Figure 1. Among them, the terminal 102 communicates with the server 104 through the network, and the data storage system can store the data that the server 104 needs to process. The data storage system can be integrated on the server 104, or it can be placed on the cloud or other network servers. Among them, the terminal 102 can be, but is not limited to, various personal computers, laptops, smart phones, tablets, Internet of Things devices, and portable wearable devices. The Internet of Things devices can be smart speakers, smart TVs, smart air conditioners, smart car-mounted devices, etc. Portable wearable devices can be smart watches, smart bracelets, head-mounted devices, etc. The server 104 can be implemented as an independent server or a server cluster consisting of multiple servers.

[0084] It should be noted that the radiotherapy dose assessment method, irradiation condition selection method, and treatment plan generation method provided in the embodiments of the present application can generally be executed by the server 104. Accordingly, the treatment plan generation device provided in the embodiments of the present application can generally be set in the server 104. The radiotherapy dose assessment method, irradiation condition selection method, and treatment plan generation method provided in the embodiments of the present application can also be executed by a server or server cluster that is different from the server 104 and can communicate with the terminal 102 device or the server 104. Accordingly, the treatment plan generation device provided in the embodiments of the present application can also be set in a server or server cluster that is different from the server 104 and can communicate with the terminal 102 device or the server 104.

[0085] It should be understood that the number of terminal devices, networks, and servers in Figure 1 is merely illustrative and any number of terminal devices, networks, and servers may be provided as required.

[0086] The basic physical principle of radiotherapy technology is to irradiate tumor tissue with radiation, and through the interaction between radiation and tumor tissue, the energy carried by the radiation is deposited into cancer cells to kill them. Its fundamental goal is to kill as many cancer cells as possible (giving tumor tissue the highest possible radiation absorption dose) while protecting healthy tissue (giving healthy tissue the lowest possible radiation absorption dose).

[0087] The radiation therapy dose assessment method, irradiation condition selection method, and treatment plan generation method provided in the embodiments of the present application can be used for radiation therapy that uses radiation for treatment, such as: traditional radiotherapy, proton radiotherapy, X-ray radiotherapy, electron beam radiotherapy, neutron capture therapy, and boron neutron capture therapy.

[0088] In radiotherapy, the Monte Carlo method can accurately simulate the collision trajectories and energy distribution of nuclear particles in the three-dimensional space of the irradiated body. During the simulation process, in order to determine the radiation absorption dose distribution of the irradiated body under certain irradiation conditions, traditional methods use computer technology to process medical imaging data and establish the precise grid model required by the Monte Carlo software. The Monte Carlo software is then used to perform dose simulation calculations. In the Monte Carlo dose calculation program, the dose D is calculated using the following formula:

[0089] Where D is the dose, is the flux, kerma is the flux dose conversion factor, and P is the parameter characterizing the particle state, where the parameters of the particle state include spatial position r, angle Ω, and energy E.

[0090] flux Calculate using formula 2:

[0091] Among them, P1 and P2 represent different particle state parameters, S represents the source term, S(P1) represents the number of particles in the P1 state under the initial source state, K is the transport nuclear parameter in the nuclear reaction database, and K(P2→P1) represents the collision probability of particles from the P2 state to the P1 state.

[0092] According to formula 2, the flux of particles in the P1 state is It consists of two parts. The first part is the number of particles in the P1 state in the initial source state, and the second part is the number of particles in other states (different from the P1 state) that reach the P1 state through collision reactions. Formula 2 integrates all P2s, that is, it summarizes the number of particles in all states different from the P1 state that are converted into P1.

[0093] In the above-mentioned dose simulation calculation using the Monte Carlo method, the flux The calculation of is a complex and time-consuming process, resulting in low efficiency of dose calculation. Moreover, in radiotherapy technology, it is often necessary to calculate a large number of dose distributions of tissue materials under different irradiation conditions, so as to select appropriate irradiation conditions based on the dose distributions of tissue materials under different irradiation conditions. Different irradiation conditions are essentially different source terms S. Combining the above formulas 1 and 2, it can be seen that the flux It is related to the source term S, that is, it is related to the irradiation conditions. When calculating the dose D of tissue materials under different irradiation conditions, for each irradiation condition, the flux corresponding to the irradiation condition must be calculated. The flux The calculation of flux is complex and time-consuming. When calculating the dose, it often takes a lot of time to calculate the dose distribution of tissue materials under various irradiation conditions, making it difficult to select appropriate irradiation conditions in a short time.

[0094] Based on this, in order to be able to quickly assess the radiation absorbed dose of tissue materials, and to quickly assess the radiation absorbed dose of tissue materials under different irradiation conditions, so as to facilitate the rapid identification of appropriate irradiation conditions, an embodiment of the present application provides a method for assessing radiation therapy dose. In one embodiment, as shown in FIG2 , the method includes the following steps:

[0095] Get organizational material information:

[0096] Tissue material information includes elemental information, such as the elemental composition and element ratio of the tissue material. Human tissue contains more than 60 elements, of which more than 20 are essential elements, which are important for maintaining normal physiological functions. Elements with higher content include carbon, hydrogen, oxygen, nitrogen, sodium, phosphorus, magnesium, potassium, and calcium. In addition, blood tissue contains small amounts of iron, and thyroid tissue contains small amounts of iodine.

[0097] In addition, in some radiotherapy techniques, before the controlled therapeutic beam is irradiated to the body to be irradiated, targeted molecular drugs are injected into the body to be irradiated, so as to utilize the selectivity of targeted molecular drugs to make the targeted elements specifically accumulate in certain tissues. For example, in boron neutron capture therapy, boron-containing ( 10 B) Drugs selectively accumulate in tumor tissues, using boron ( 10 B) It has a high capture cross section for thermal neutrons, achieving the goal of locally killing tumor cells. In this application scenario, the elemental composition of the tissue material can also include the targeted element, and the elemental ratio of the tissue material can also include the ratio of the targeted element.

[0098] In radiotherapy, medical images such as magnetic resonance imaging (MRI) and computed tomography (CT) can provide relatively detailed information on tissue geometry for features within the body to be irradiated. Taking CT as an example, tissue materials can be defined based on CT values, also known as Hounsfield Units (HUs). HU values ​​within a fixed range correspond to tissue materials with a fixed elemental composition ratio. For example, HU values ​​between -100 and 20 correspond to adipose tissue with a fixed elemental composition ratio, HU values ​​between 20 and 100 correspond to muscle tissue with a fixed elemental composition ratio, and HU values ​​between -951 and 120 correspond to lung tissue with a fixed elemental composition ratio.

[0099] When implementing the conversion between medical imaging data and tissue materials and tissue material information in the embodiments of the present application, some tissue materials may cover a wide range of HU values, resulting in lower accuracy in dose calculation. In this case, the tissue materials covering a wide range of HU values ​​can be further divided. For example, lung tissue can be divided into low-density lung tissue and high-density lung tissue.

[0100] For radiotherapy techniques including targeted elements, the embodiments of the present application can assume that the concentration distribution of the targeted elements in part or all of the tissue materials is non-uniform, and obtain non-uniform targeted element distribution information through medical images such as positron emission computed tomography (PET), so as to further divide part or all of the tissue materials according to the targeted element distribution information. For example, tumor tissue materials can be further divided into multiple tissue materials based on boron concentration, so as to more accurately evaluate the radiation absorption dose of tumor tissue materials with different boron concentrations.

[0101] In the embodiments of this application, different tissue materials need to be considered or used for dose calculation for tumors in different locations. For head and neck cancer, the tissue materials that need to be considered generally include skin, brain, brainstem, eye, mucosa, mandible, spinal cord, and tumor. In the embodiments of this application, the geometric space of the tissue materials that need to be considered can be delineated based on the medical images of the object to be irradiated.

[0102] It should be noted that acquiring tissue material information in the embodiment of the present application specifically refers to acquiring information of target tissue materials for subsequent dose assessment.

[0103] It should be noted that the embodiment of the present application does not specifically limit the definition of tissue materials, that is, the conversion relationship between medical imaging data and tissue materials. The tissue materials that require dose assessment can be defined based on the actual accuracy requirements of dose assessment and the location of the tumor.

[0104] It should be noted that the embodiments of the present application do not specifically limit the method for obtaining tissue material information. For example, in proton radiotherapy, the HU value can be converted into the corresponding tissue material according to a specific relationship through TOPAS software, and the tissue material element information defined by default in the TOPAS software can be obtained; for example, in boron neutron capture therapy, the material template library of MCNP software and PET medical imaging data or blood boron concentration can be combined to obtain tissue material information.

[0105] According to the tissue material information, determine the conjugate flux corresponding to the tissue material:

[0106] The conjugate flux corresponding to the tissue material includes distribution information of the conjugate flux in the geometric space of the tissue material.

[0107] For example, after obtaining tissue material information, the conjugate flux corresponding to the tissue material is determined based on the elemental information in the tissue material information. The conjugate flux is unrelated to the variable source term S, i.e., the parameters of the radiation. Therefore, when using the radiotherapy dose assessment method provided in the embodiments of the present application to calculate dose distributions under multiple irradiation conditions, the conjugate flux corresponding to a tissue material only needs to be calculated once. That is, the number of conjugate flux calculations is related only to the number of tissue material types to be considered, and is not related to the number of irradiation conditions.

[0108] Based on the irradiation conditions and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to the tissue material under the irradiation conditions is obtained:

[0109] Among them, the irradiation conditions include the irradiation direction, irradiation position and beam parameters of the radioactive particles. Different irradiation conditions are essentially different source terms S. Under different irradiation conditions, different radioactive particles have different distribution states. The source term S can be expressed by the particle distribution function.

[0110] Exemplarily, after determining the conjugate flux corresponding to the tissue material, based on the irradiation conditions and in combination with the conjugate flux corresponding to the tissue material, the radiation absorption dose corresponding to the tissue material under the irradiation conditions can be determined. For example, based on the conjugate flux corresponding to the tumor tissue and the given irradiation conditions, the radiation absorption dose corresponding to the tumor tissue under the irradiation conditions can be obtained.

[0111] In radiotherapy technology, it is often necessary to calculate the dose distribution of tissue materials under different irradiation conditions. For example, in order to select the appropriate irradiation condition from 100 irradiation conditions, it is necessary to calculate the dose D of radioactive particles corresponding to the 100 irradiation conditions. Calculate the dose D, the flux Formula 2 is used for calculation. According to formula 2, the flux can be known Related to the source term S, it is equivalent to calculating the flux for each irradiation condition You need to calculate the flux 100 times Only then can the dose D corresponding to 100 irradiation conditions be obtained; and when the conjugate flux provided in the embodiment of the present application is used to calculate the dose D, since the conjugate flux is not associated with the source term S, the number of calculations is only related to the counting target of the type of tissue material to be considered. Therefore, for different irradiation conditions, the conjugate flux corresponding to the tissue material is the same, and the conjugate flux provided in the embodiment of the present application is used to calculate the dose D. It is only necessary to calculate the conjugate flux several times, and then combine the 100 irradiation conditions to calculate the dose D corresponding to the tissue material under each irradiation condition. The specific number depends on the number of tissue material types to be considered, generally the number of tumor tissues and normal tissues, and the number of tissue materials is obviously much smaller than the number of irradiation conditions to be considered. And the calculated flux It is a very complicated process, and the calculation of conjugate flux is more complicated than flux. The calculation of the dose D under multiple irradiation conditions is relatively simple, and the calculation of the dose D under the combination of irradiation conditions and conjugate flux is also relatively simple. Therefore, the calculation of the dose D under multiple irradiation conditions using conjugate flux is more convenient than using flux. Calculating the dose D under multiple irradiation conditions is significantly faster.

[0112] In the above-mentioned radiotherapy dose assessment method, tissue material information is first obtained. Based on the tissue material information, the conjugate flux corresponding to the tissue material is determined. Based on the irradiation conditions, the conjugate flux corresponding to the tissue material is combined to obtain the radiation absorbed dose corresponding to the tissue material under the irradiation conditions. Since the calculation of the conjugate flux is relatively simple, and the calculation of the radiation absorbed dose based on the irradiation conditions and the conjugate flux is also relatively simple, the above-mentioned method can quickly assess the radiation absorbed dose corresponding to the tissue material. Moreover, when the above-mentioned method is used to assess the dose distribution under multiple irradiation conditions, since the conjugate flux is independent of the source term S, the number of calculations is only related to the counting target of the tissue material to be considered. Therefore, regardless of how the irradiation conditions change, the conjugate flux corresponding to the tissue material is determined. Therefore, using the above-mentioned radiotherapy dose assessment method, only a few conjugate flux calculations are required to assess the dose distribution under multiple irradiation conditions, thereby improving the efficiency of dose assessment under multiple irradiation conditions.

[0113] In one embodiment, determining the conjugate flux corresponding to the tissue material according to the tissue material information includes the following steps:

[0114] According to the element information of the tissue material in the tissue material information, the flux dose conversion factor corresponding to the tissue material is determined:

[0115] Among them, the flux dose conversion factor (Kerma) of a certain tissue material is determined by the elemental composition and element proportion of the tissue material. According to the particle energy, the flux dose conversion factor of each nuclide at the corresponding energy can be found in the cross-section database.

[0116] In one implementation method, the density of each nuclide in the tissue material is first obtained based on the elemental composition and element proportion in the tissue material, and the flux dose conversion factor corresponding to each nuclide is obtained. The flux dose conversion factor corresponding to each nuclide and the density of each nuclide are combined to determine the flux dose conversion factor corresponding to the tissue material.

[0117] In one implementation, the flux dose conversion factor corresponding to each nuclide and the density of each nuclide are combined to determine the flux dose conversion factor corresponding to the tissue material using the following formula: Kerma = ∑ρ i Kerma i ; (Formula 3)

[0118] Among them, ρ i represents the density of the i-th nuclide, Kerma i represents the flux dose conversion factor corresponding to the i-th nuclide.

[0119] According to the flux dose conversion factor corresponding to the tissue material, the conjugate flux corresponding to the tissue material is determined:

[0120] In one implementation, based on the flux dose conversion factor Kerma corresponding to the tissue material, combined with the above formula 2, a conjugate equation is constructed with the flux dose conversion factor Kerma corresponding to the tissue material as the source term, and the conjugate flux corresponding to the tissue material is determined using the conjugate equation. The conjugate equation is as follows:

[0121] in, represents the conjugate flux, P1 and P2 represent different particle state parameters, represents the conjugate flux of particles in the P1 state, Kerma represents the flux dose conversion factor, K * Represents the conjugate nuclear parameters from the Nuclear Reaction Database.

[0122] Among them, the transport core K and the conjugated core K * The following relationship is satisfied:

[0123] K(P2→P1)=K * (P1→P2); (Formula 5)

[0124] It can be seen that K in the above formula 4 * (P2→P1) is equal to K(P1→P2), which is the probability that the particle reaches the P2 state through collision reaction from the P1 state.

[0125] In this embodiment, the flux dose conversion factor corresponding to the tissue material is determined based on the elemental information of the tissue material in the tissue material information. Based on the flux dose conversion factor corresponding to the tissue material, the conjugate flux corresponding to the tissue material is determined. Referring to Formula 4, the conjugate flux is independent of the source term S and is related to the flux dose conversion factor Kerma, which corresponds to the tissue material. Different tissue materials have different nuclides with different densities, and different nuclides correspond to different Kerma values. By combining the density of each nuclide in the tissue material and the Kerma value corresponding to each nuclide, the Kerma value corresponding to the tissue material can be obtained. Then, according to Formula 4, the conjugate flux corresponding to the tissue material is determined based on the Kerma value corresponding to the tissue material.

[0126] In one embodiment, based on the irradiation conditions and in combination with the conjugate flux corresponding to the tissue material, obtaining the radiation absorbed dose corresponding to the tissue material under the irradiation conditions includes:

[0127] Based on the irradiation conditions, the source term distribution corresponding to the irradiation conditions is determined:

[0128] Among them, the source term distribution is the source term S, which is used to characterize the distribution function of the particle source under irradiation conditions.

[0129] According to the source term distribution and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to the tissue material is obtained:

[0130] Please combine Formula 2 and Formula 4 and compare the two sides of the equal sign of Formula 2 with Do the inner product and compare the two sides of the equation Doing the inner product gives:

[0131] According to Formula 5, Formula 6 and Formula 7, the two double integrals on the right side of the equal sign are equal. Eliminating the equal parts yields:

[0132] Combining Formula 1, Formula 2, Formula 4 and Formula 8, we can get:

[0133] Formula 9 shows that the dose can be expressed as The inner product of the flux-dose conversion factor Kerma can also be obtained by conjugating the flux The inner product with the source term S is obtained.

[0134] In this embodiment, the source term distribution function corresponding to the irradiation condition is determined by the irradiation condition, and then the radiation absorption dose corresponding to the region of interest is obtained by taking the inner product of the source term distribution function and the conjugate flux corresponding to the tissue material. is a complex and time-consuming process, and conjugate flux The calculation of the flux The calculation of is relatively simple, and the calculation of the inner product is also relatively simple. Therefore, the above method can quickly evaluate the radiation absorption dose corresponding to the tissue material. Moreover, when evaluating the dose distribution under multiple irradiation conditions, for example, in order to select the appropriate irradiation condition from 100 irradiation conditions, the conjugate flux provided in the embodiment of the present application is used. To calculate the dose D, we only need to calculate the conjugate flux several times The specific number depends on the counting target of the tissue material to be considered, and the conjugate flux is The dose D corresponding to different source terms can be obtained by performing 100 inner products with the source term distribution function, which can greatly save the dose assessment time and improve the efficiency of dose assessment.

[0135] Based on the same inventive concept, embodiments of the present application also provide a method for selecting irradiation conditions. The solution provided by this method for selecting irradiation conditions is similar to the solution described in the aforementioned method for assessing radiotherapy doses. Therefore, the specific limitations in one or more of the following embodiments of the method for selecting irradiation conditions can be found in the aforementioned embodiments of the method for assessing radiotherapy doses, and are not further elaborated here.

[0136] In one embodiment, as shown in FIG3 , a method for selecting an irradiation condition is provided, comprising the following steps:

[0137] Combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to each tissue material is obtained:

[0138] Among them, when selecting appropriate irradiation conditions, it is required that high doses of radiation be delivered to the tumor target area as much as possible to minimize damage to surrounding organs (healthy tissues). In order to better control the dose distribution within each organ or target area, appropriate irradiation conditions are selected so that the radiation can kill tumor cells while minimizing damage to surrounding normal tissues. The tissue material of the embodiment of the present application may include tumor tissue and at least one important organ tissue in the surrounding area.

[0139] In one implementation, multiple irradiation conditions can be pre-determined based on tumor type, location, and size, using the physicist's experience. Sampling from these multiple irradiation conditions involves selecting a specific irradiation condition, either randomly or in a pre-determined order. The radiation absorbed dose corresponding to each tissue material under this irradiation condition is then determined by combining the irradiation condition with the conjugate flux corresponding to each tissue material.

[0140] According to the radiation absorbed dose corresponding to each tissue material, select at least one appropriate irradiation condition:

[0141] In one implementation, if the radiation absorbed dose corresponding to each tissue material meets the preset conditions, the irradiation conditions are accepted; if the radiation absorbed dose corresponding to each tissue material does not meet the preset conditions, the irradiation conditions are resampled and the radiation absorbed dose corresponding to each tissue material under the resampled irradiation conditions is evaluated.

[0142] Exemplarily, the tissue material includes tumor tissue material and vital organ tissue material. If the radiation absorption dose corresponding to the tumor tissue material is greater than a first preset threshold, and the radiation absorption dose corresponding to the vital organ tissue material is less than a second preset threshold, the irradiation condition is accepted as a suitable irradiation condition.

[0143] In one implementation, multiple irradiation conditions are optimized according to the radiation absorption dose corresponding to each tissue material, so as to select at least one suitable irradiation condition.

[0144] For example, for each radiation absorption dose corresponding to each tissue material under each irradiation condition, the irradiation conditions that meet the preset conditions are first screened out, and then the multiple irradiation conditions that meet the preset conditions are sorted and optimized. The optimization can be determined by comparing the radiation absorption dose corresponding to the tumor tissue under each irradiation condition, and comparing the radiation absorption dose corresponding to other important organ tissue materials under each irradiation condition. Different weights can also be assigned to different tissue materials according to actual conditions to achieve optimization. The embodiments of the present application are not specifically limited here.

[0145] It should be noted that it is preferred to select a single optimal irradiation condition or to select multiple relatively optimal irradiation conditions, with the optimal or relatively optimal irradiation conditions being the appropriate irradiation condition. Alternatively, when multiple relatively optimal irradiation conditions are selected, a Monte Carlo simulation program can be used to calculate more accurate dose distributions under the multiple relatively optimal irradiation conditions based on the fluxes corresponding to the multiple relatively optimal irradiation conditions, and then compare them to determine the appropriate irradiation condition.

[0146] In this embodiment, the radiation absorbed dose corresponding to each tissue material is obtained by combining the irradiation conditions and the conjugate flux corresponding to the tissue material. Based on the radiation absorbed dose corresponding to each tissue material, at least one appropriate irradiation condition is selected. Since the conjugate flux is independent of the source term S and the number of calculations is only related to the counting target of the tissue material to be considered, the conjugate flux corresponding to the tissue material is fixed regardless of how the irradiation conditions change. Therefore, using the above irradiation condition selection method, only a few conjugate flux calculations are required to evaluate the radiation absorbed dose of each tissue material under multiple irradiation conditions. This improves the efficiency of dose calculation under multiple irradiation conditions, enables rapid evaluation of the radiation absorbed dose corresponding to each tissue material under different irradiation conditions, and facilitates the rapid selection of the appropriate irradiation condition from multiple irradiation conditions.

[0147] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes: determining the tissue material corresponding to the region of interest based on at least one preset region of interest.

[0148] Among them, the region of interest (ROI) can be the target area for particle deposition, such as the tumor area that needs to be treated. The region of interest can also be a protective area around the target area, such as the area where important organs and tissues are located. It can be a key organ such as the eyes, liver, etc., or it can be an important tissue such as bone tissue, brain tissue, etc.

[0149] In the embodiment of the present application, at least one ROI region that needs to be defined for different tumor types can be pre-set. For example, the ROI types that need to be paid attention to during brain tumor treatment may include air, skin, carotid artery, mucosa, brain tissue, eyeball, lens, gland, bone, soft tissue, or brain tumor, etc.

[0150] Based on medical imaging data, such as HU values, corresponding ROI boundaries can be automatically defined, automatically read, or manually defined by the operator. Through the definition of ROI boundaries, the three-dimensional medical imaging geometric model of the irradiated body is divided into corresponding ROI areas, that is, each voxel grid is divided into the corresponding ROI area.

[0151] After presetting at least one ROI region, the present embodiment determines the tissue material corresponding to each ROI region. For example, a material template library pre-sets the HU value range corresponding to each ROI region, one or more tissue material types corresponding to different ROI regions, the HU values ​​corresponding to the tissue materials, and the element information corresponding to the tissue materials.

[0152] For example, some ROI regions cover a narrower range of HU values, and one ROI region may correspond to one tissue material.

[0153] For example, some ROI regions cover a wider range of HU values. The ROI region can be further divided into different tissue material types according to different HU value ranges to obtain multiple tissue materials corresponding to the ROI region.

[0154] It should be noted that in a radiotherapy application scenario including a targeted element, this embodiment assumes that the concentration distribution of the targeted element in the ROI region is a uniform concentration distribution.

[0155] In this embodiment, by selecting at least one preset region of interest, the type of tissue material corresponding to the region of interest is determined based on the tissue density in the medical imaging data, and one or more tissue materials corresponding to the region of interest are obtained, so that the radiation absorption dose of the tissue material can be evaluated more accurately.

[0156] In another embodiment, before obtaining the radiation absorption dose corresponding to each tissue material in combination with the irradiation conditions and the conjugate flux corresponding to the tissue material, it includes: based on at least one preset region of interest, combined with the concentration distribution of the target element in the region of interest, determining the tissue material corresponding to the region of interest.

[0157] This embodiment is applied to a radiotherapy scenario including a targeted element. In this embodiment, the concentration distribution of the targeted element in the ROI region is assumed to be a partially non-uniform or completely non-uniform concentration distribution.

[0158] For example, after the ROI region is preset, the initial tissue material type of the ROI region can be determined based on the HU value of the ROI region, and then based on the non-uniform concentration distribution information of the targeted element, some or all of the tissue materials in the initial tissue material type can be further divided. For example, in boron neutron capture therapy, a certain ROI region is delineated according to the HU value to correspond to a tissue material, and the tissue material is tumor tissue. Furthermore, the non-uniform boron nuclide concentration distribution information in the ROI region can be obtained through medical imaging such as PET, and based on the non-uniform boron nuclide concentration distribution information, the ROI region can be further divided into tumor 1 tissue material, tumor 2 tissue material, tumor 3 tissue material, etc.

[0159] In this embodiment, the tissue material corresponding to the region of interest is determined by combining the concentration distribution of the targeting element within the region of interest. Because the targeting element also has a corresponding flux dose conversion factor, Kerma, in the calculation of the radiation absorbed dose of the tissue material, the non-uniform distribution of the targeting element may affect the flux dose conversion factor, Kerma, corresponding to the tissue material, thereby causing deviations in the radiation absorbed dose of the tissue material. Therefore, this embodiment can further divide the tissue material within the region of interest based on the concentration distribution of the targeting element, thereby more accurately assessing the radiation absorbed dose of the tissue material.

[0160] In one embodiment, appropriate irradiation conditions are selected based on the radiation absorbed dose corresponding to each tissue material, including:

[0161] Determine the radiation absorbed dose of the region of interest based on the radiation absorbed dose corresponding to all tissue materials in the region of interest:

[0162] Before obtaining the radiation absorbed dose corresponding to each tissue material, when a region of interest is selected, appropriate irradiation conditions can be selected according to the total radiation absorbed dose in the region of interest.

[0163] For example, when there is only one type of tissue material in the region of interest, the total radiation absorbed dose in the region of interest is the absorbed dose of the tissue material corresponding to the region of interest.

[0164] For example, when the region of interest includes multiple tissue materials, the total deposition energy of all tissue materials can be divided by the regional mass of the region of interest to obtain the radiation absorbed dose of the region of interest, that is, the total average dose of the region of interest is used as the radiation absorbed dose of the region of interest. The radiation absorbed dose of the region of interest can be calculated using the following formula:

[0165] Among them, E i_deposite represents the total deposited energy corresponding to the i-th tissue material, M i represents the mass of the i-th tissue material, D i represents the radiation absorbed dose corresponding to the i-th tissue material.

[0166] Select appropriate irradiation conditions based on the radiation absorbed dose of the area of ​​interest.

[0167] In this embodiment, after selecting the region of interest and dividing the tissue materials within the region of interest, the radiation absorbed dose corresponding to the tissue materials is determined by the conjugate flux and the irradiation conditions. The radiation absorbed dose of the region of interest is determined by the radiation absorbed dose corresponding to all tissue materials within the region of interest and the mass of all tissue materials. The appropriate irradiation conditions are selected by judging whether the radiation absorbed dose of the region of interest meets the preset conditions.

[0168] Based on the same inventive concept, an embodiment of the present application also provides a treatment plan generation method, which adopts the above-mentioned irradiation condition selection method to realize the generation of the treatment plan, combines the irradiation conditions and the conjugate flux corresponding to the tissue material to obtain the radiation absorption dose corresponding to each tissue material, selects at least one suitable irradiation condition according to the radiation absorption dose corresponding to each tissue material, and generates a treatment plan according to the suitable irradiation condition.

[0169] Among them, the radiation absorbed dose corresponding to each tissue material is obtained by combining the irradiation conditions and the conjugate flux corresponding to the tissue material. The step of selecting at least one suitable irradiation condition based on the radiation absorbed dose corresponding to each tissue material is the same as the implementation scheme described in the above-mentioned irradiation condition selection method. Therefore, the specific limitations in one or more treatment plan generation method embodiments provided below can be referred to the limitations of the irradiation condition selection method above and will not be repeated here.

[0170] In one embodiment, as shown in FIG4 , the treatment plan generation method includes: combining the irradiation conditions and the conjugate flux corresponding to the tissue material to obtain the radiation absorption dose corresponding to each tissue material; selecting at least one suitable irradiation condition based on the radiation absorption dose corresponding to each tissue material; and generating a treatment plan based on the suitable irradiation condition.

[0171] In one embodiment, at least one suitable irradiation condition is selected based on the radiation absorption dose corresponding to each tissue material, including: if the radiation absorption dose corresponding to each tissue material meets a preset condition, then the irradiation condition is accepted.

[0172] In one embodiment, the tissue material includes tumor tissue material and vital organ tissue material. If the radiation absorption dose corresponding to each tissue material meets the preset conditions, the irradiation condition is accepted, including: if the radiation absorption dose corresponding to the tumor tissue material is greater than a first preset threshold, and the radiation absorption dose corresponding to the vital organ tissue material is less than a second preset threshold, the irradiation condition is accepted.

[0173] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes: determining the tissue material corresponding to the region of interest based on at least one preset region of interest.

[0174] In one embodiment, before obtaining the radiation absorbed dose corresponding to each tissue material by combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the method includes: determining the tissue material corresponding to the region of interest based on at least one preset region of interest and the concentration distribution of the target element in the region of interest.

[0175] In one embodiment, selecting appropriate irradiation conditions according to the radiation absorption dose corresponding to each tissue material includes: determining the radiation absorption dose of the region of interest according to the radiation absorption dose corresponding to all tissue materials in the region of interest; and selecting appropriate irradiation conditions according to the radiation absorption dose of the region of interest.

[0176] In one embodiment, generating a treatment plan according to appropriate irradiation conditions includes: determining a corresponding flux according to the appropriate irradiation conditions, and calculating a dose distribution based on the flux using a Monte Carlo simulation program.

[0177] It should be understood that, although the steps in the flowcharts of the above embodiments are shown in sequence as indicated by the arrows, these steps are not necessarily performed in the order indicated by the arrows. Unless otherwise specified herein, there is no strict order restriction on the execution of these steps, and these steps can be performed in other orders. Moreover, at least a portion of the steps in the flowcharts of the above embodiments may include multiple steps or multiple stages, and these steps or stages are not necessarily performed at the same time, but can be performed at different times. The execution order of these steps or stages is not necessarily to be performed in sequence, but can be performed in turn or alternately with other steps or at least a portion of steps or stages in other steps.

[0178] Based on the same inventive concept, embodiments of the present application also provide a treatment plan generation device for implementing the aforementioned treatment plan generation method. The solution provided by the treatment plan generation device is similar to the solution described in the aforementioned treatment plan generation method. Therefore, the specific limitations in one or more of the following treatment plan generation device embodiments can be found in the aforementioned limitations on the treatment plan generation method and will not be further elaborated here.

[0179] In one embodiment, as shown in FIG5 , a treatment plan generating apparatus is provided. The treatment plan generating apparatus includes a radiation source module 502 , a medical impact data module 504 , a dose assessment module 506 , an irradiation condition selection module 508 , and a treatment plan generating module 510 , wherein:

[0180] The radiation source module 502 is used to establish source term information according to different irradiation conditions.

[0181] The medical image data module 504 is used to obtain tissue material information based on medical image data and establish a three-dimensional voxel tissue model.

[0182] The dose assessment module 506 is used to determine the conjugate flux corresponding to the tissue material according to the tissue material information, and to obtain the radiation absorbed dose corresponding to each tissue material by combining the source term information and the conjugate flux corresponding to the tissue material.

[0183] The irradiation condition selection module 508 is used to select at least one appropriate irradiation condition according to the radiation absorption dose corresponding to each tissue material.

[0184] The treatment plan generating module 510 is used to generate a treatment plan according to appropriate irradiation conditions.

[0185] Each module in the treatment plan generation device described above may be implemented in whole or in part through software, hardware, or a combination thereof. Each module may be embedded in or independent of a processor within a computer device in the form of hardware, or may be stored in a memory within the computer device in the form of software, so that the processor can call and execute the corresponding operations of each module.

[0186] Based on the same inventive concept, an embodiment of the present application further provides a radiotherapy system. The implementation solution provided by the radiotherapy system is similar to the implementation solution described in the above-mentioned treatment plan generation method or treatment plan generation device. Therefore, the specific limitations in one or more radiotherapy system embodiments provided below can refer to the limitations of the treatment plan generation method or treatment plan generation device above and will not be repeated here.

[0187] In one embodiment, as shown in FIG6 , a radiotherapy system is provided. The radiotherapy system includes a beam generating device 602 , a beam adjusting device 604 , a treatment plan generating device 606 , and a beam controlling device 608 , wherein:

[0188] The beam generating device 602 is used to generate a therapeutic beam.

[0189] The beam adjusting device 604 is used to adjust the treatment beam generated by the beam generating device 602 .

[0190] Treatment plan generating device 606 is used to establish source term information based on different irradiation conditions, obtain tissue material information based on medical imaging data, establish a three-dimensional voxel tissue model, determine the conjugate flux corresponding to the tissue material based on the tissue material information, combine the source term information and the conjugate flux corresponding to the tissue material to obtain the radiation absorbed dose corresponding to each tissue material, select at least one appropriate irradiation condition based on the radiation absorbed dose corresponding to each tissue material, and generate a treatment plan based on the appropriate irradiation condition.

[0191] The beam control device 608 is used to retrieve the corresponding treatment plan from the treatment plan generating device 606 and control the beam generating device 602 to execute the treatment plan.

[0192] Based on the same inventive concept, an embodiment of the present application also provides another radiotherapy system, which can be a server, and its internal structure diagram can be shown in Figure 7. The computer device includes a processor, memory, an input / output (I / O) interface, and a communication interface. The processor, memory, and I / O interface are connected via a system bus, and the communication interface is connected to the system bus via the I / O interface. The processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and internal memory. The non-volatile storage medium stores an operating system, a computer program, and a database. The internal memory provides an environment for the operation of the operating system and computer program in the non-volatile storage medium. The database of the computer device is used to store data such as tissue material information. The I / O interface of the computer device is used to exchange information between the processor and external devices. The communication interface of the computer device is used to communicate with external terminals via a network connection. When executed by the processor, the computer program implements a radiotherapy dose assessment method, an irradiation condition selection method, or a treatment plan generation method.

[0193] Those skilled in the art will understand that the structure shown in Figure 7 is merely a block diagram of a portion of the structure related to the scheme of the present application, and does not constitute a limitation on the radiotherapy system to which the scheme of the present application is applied. A specific radiotherapy system may include more or fewer components than shown in the figure, or combine certain components, or have a different arrangement of components.

[0194] In one embodiment, a radiotherapy system is provided, comprising a memory and a processor. The memory stores a computer program, and the processor implements the steps in the above-mentioned method embodiments when executing the computer program.

[0195] In one embodiment, a computer-readable storage medium is provided, on which a computer program is stored. When the computer program is executed by a processor, the steps in the above-mentioned method embodiments are implemented.

[0196] Those skilled in the art will appreciate that all or part of the processes in the above-mentioned embodiments can be implemented by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to memory, database or other media used in the embodiments provided in this application may include at least one of non-volatile and volatile memory. Non-volatile memory may include read-only memory (ROM), magnetic tape, floppy disk, flash memory, optical memory, high-density embedded non-volatile memory, resistive random access memory (ReRAM), magnetic random access memory (MRAM), ferroelectric random access memory (FRAM), phase change memory (PCM), graphene memory, etc. Volatile memory may include random access memory (RAM) or external cache memory, etc. By way of illustration and not limitation, RAM may be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM).

[0197] The technical features of the above embodiments can be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0198] The above embodiments merely illustrate several implementation methods of the present application. While the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the present invention. It should be noted that a person skilled in the art may make various modifications and improvements without departing from the spirit of the present invention, all of which fall within the scope of protection of the present application. Therefore, the scope of protection of the present application shall be determined by the appended claims.

Claims

1. A method for assessing radiation therapy dose, characterized in that: The method comprises: Obtain information about organizational materials; Determining the conjugate flux corresponding to the tissue material according to the tissue material information; Based on the irradiation conditions and in combination with the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to the tissue material under the irradiation conditions is obtained.

2. The method according to claim 1, characterized in that Determining the conjugate flux corresponding to the tissue material according to the tissue material information includes: Determining a flux dose conversion factor corresponding to the tissue material according to the element information of the tissue material in the tissue material information; The conjugate flux corresponding to the tissue material is determined according to the flux dose conversion factor corresponding to the tissue material.

3. The method according to claim 2, characterized in that The element information includes element composition and element proportion, and determining the flux dose conversion factor corresponding to the tissue material according to the element information of the tissue material in the tissue material information includes: According to the element composition and the element proportion, obtaining the density of each nuclide in the tissue material; Obtaining the flux dose conversion factor corresponding to each nuclide; The flux dose conversion factor corresponding to the tissue material is determined by combining the flux dose conversion factor corresponding to each nuclide and the density of each nuclide.

4. The method according to claim 3, characterized in that The flux dose conversion factor corresponding to each nuclide and the density of each nuclide are combined to determine the flux dose conversion factor corresponding to the tissue material, using the following formula: Kerma = ∑ρ i ·Kerma i ; Among them, ρ i represents the density of the ith nuclide, Kerma i Represents the flux dose conversion factor corresponding to the i-th nuclide.

5. The method according to claim 2, characterized in that: The conjugate flux corresponding to the tissue material is determined according to the flux dose conversion factor corresponding to the tissue material, using the following formula: in, represents the conjugate flux, P1 and P2 represent different particle state parameters, represents the conjugate flux of the particle in the P1 state, Kerma represents the flux dose conversion factor, K * represents the conjugate nucleus, K * (P2→P1) represents the probability that a particle reaches the P2 state from the P1 state through a collision reaction.

6. The method according to claim 1, characterized in that The step of obtaining the radiation absorbed dose corresponding to the tissue material under the irradiation condition based on the irradiation condition and in combination with the conjugate flux corresponding to the tissue material comprises: Based on the irradiation condition, determining a source term distribution corresponding to the irradiation condition, wherein the source term distribution is used to characterize a distribution function of a particle source under the irradiation condition; The radiation absorption dose corresponding to the tissue material is obtained according to the source term distribution and the conjugate flux corresponding to the tissue material.

7. A method for selecting irradiation conditions, characterized in that: The method comprises: Combining the irradiation conditions and the conjugate flux corresponding to the tissue material, the radiation absorbed dose corresponding to each tissue material is obtained; At least one suitable irradiation condition is selected according to the radiation absorption dose corresponding to each tissue material.

8. The method according to claim 7, characterized in that The step of selecting at least one suitable irradiation condition according to the radiation absorption dose corresponding to each tissue material comprises: If the radiation absorption doses corresponding to the various tissue materials meet the preset conditions, the irradiation conditions are accepted.

9. The method according to claim 8, characterized in that The tissue material at least includes tumor tissue material and important organ tissue material, and if the radiation absorption doses corresponding to the various tissue materials meet the preset conditions, then the irradiation conditions are accepted, including: If the radiation absorption dose corresponding to the tumor tissue material is greater than a first preset threshold, and the radiation absorption dose corresponding to the important organ tissue material is less than a second preset threshold, the irradiation condition is accepted.

10. The method according to claim 7, characterized in that Before combining the irradiation conditions and the conjugate flux corresponding to the tissue material to obtain the radiation absorption dose corresponding to each tissue material, the method includes: Based on at least one preset region of interest, a tissue material corresponding to the region of interest is determined.

11. The method according to claim 7, characterized in that Before combining the irradiation conditions and the conjugate flux corresponding to the tissue material to obtain the radiation absorption dose corresponding to each tissue material, the method includes: Based on at least one preset region of interest and in combination with the concentration distribution of the targeting element in the region of interest, the tissue material corresponding to the region of interest is determined.

12. The method according to claim 10 or 11, characterized in that: The step of selecting appropriate irradiation conditions according to the radiation absorption doses corresponding to the various tissue materials comprises: Determining the radiation absorbed dose of the region of interest according to the radiation absorbed doses corresponding to all tissue materials in the region of interest; According to the radiation absorbed dose of the region of interest, appropriate irradiation conditions are selected.

13. A treatment plan generating device, characterized in that: include: A radiation source module is used to establish source term information according to different irradiation conditions; A medical imaging data module, used to obtain tissue material information based on medical imaging data and establish a three-dimensional voxel tissue model; A dose assessment module, used to determine the conjugate flux corresponding to the tissue material according to the tissue material information, and to obtain the radiation absorption dose corresponding to each tissue material by combining the source term information and the conjugate flux corresponding to the tissue material; The irradiation condition selection module is used to select at least one suitable irradiation conditions; The treatment plan generating module is used to generate a treatment plan according to the appropriate irradiation conditions.

14. A radiotherapy system, characterized in that: include: A beam generating device for generating a therapeutic beam; a beam adjustment device, used for adjusting the therapeutic beam generated by the beam generating device; A treatment plan generating device, used to establish source term information according to different irradiation conditions, obtain tissue material information based on medical image data, establish a three-dimensional voxel tissue model, determine the conjugate flux corresponding to the tissue material according to the tissue material information, combine the source term information and the conjugate flux corresponding to the tissue material to obtain the radiation absorption dose corresponding to each tissue material, select at least one suitable irradiation condition according to the radiation absorption dose corresponding to each tissue material, and generate a treatment plan according to the suitable irradiation condition; The beam control device is used to retrieve the corresponding treatment plan from the treatment plan generating device and control the beam generating device to execute the treatment plan.

Citation Information

Patent Citations

  • Radiotherapy reverse optimization method and device in combination with Monte Carlo, and storage medium

    CN110570923A

  • Radiotherapy system and treatment plan generation method thereof

    CN113797447A

  • Dose planning system

    CN115702984A

  • Deterministic computation of radiation transport for radiotherapy dose calculations and scatter correction for image reconstruction

    US20060259282A1

  • Method and system for the calculation of dose responses for radiotherapy treatment planning

    US20080004845A1